Amphastar Pharmaceuticals, Inc.

AMPH · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$151,609$144,296$156,098$126,353
Short-Term Investments$70,036$112,510$19,664$10,320
Receivables$138,036$115,469$88,804$78,804
Inventory$153,741$105,833$103,584$92,807
Other Curr. Assets$20,649$11,492$2,606$2,561
Total Curr. Assets$534,071$489,600$378,319$318,119
Property Plant & Equip (Net)$344,627$315,643$264,573$271,491
Goodwill$3,049$3,216$3,126$3,313
Intangibles$587,611$610,079$34,172$35,557
Long-Term Investments$10,996$15,212$2,414$3,985
Tax Assets$71,124$53,252$38,527$22,399
Other NC Assets$25,992$25,910$20,856$16,665
Total NC Assets$1,043,399$1,023,312$363,668$353,410
Other Assets$0$0$0$0
Total Assets$1,577,470$1,512,912$741,987$671,529
Liabilities
Payables$30,514$25,438$20,501$22,214
Short-Term Debt$234$436$3,046$2,202
Tax Payable$9,664$1,609$4,571$9,081
Deferred Revenue$0$0$0$0
Other Curr. Liab.$0$0$17,553$23,161
Total Curr. Liab.$173,759$225,407$94,862$103,810
LT Debt$601,630$589,579$72,839$74,378
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$6,957$6,066$7,369$7,065
Other NC Liab.$20,945$22,718$14,565$15,653
Total NC Liab.$671,413$648,084$118,467$122,197
Other Liabilities$0$0$0$0
Cap. Leases$48,685$33,627$26,697$27,685
Total Liabilities$845,172$873,491$213,329$226,007
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings$568,787$409,268$271,723$180,337
AOCI-$9,181-$8,478-$8,624-$6,765
Other Equity$0$0$0$0
Total Equity$732,298$639,421$528,658$445,522
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,577,470$1,512,912$741,987$671,529
Net Debt$450,255$445,719-$80,213-$49,773